• Maryland drug company cuts COO role, to lay off 400

    Emergent BioSolutions, a Gaithersburg, Md.-based company that makes multiple vaccines and achieved the first FDA approval for an over-the-counter naloxone nasal spray, plans to reduce operations at three facilities, lay off about 400 workers and cut its COO role. 
  • Wegovy reduces cardiovascular risks in phase 3 trial

    Novo Nordisk's Wegovy, a weight loss drug, showed a 20 percent reduction in major adverse cardiovascular events in a phase 3 trial, the drugmaker said Aug. 8.
  • Sage ponders cutting jobs, delaying drug pricing after partial approval

    After the FDA approved a Sage Therapeutics drug for postpartum depression but not major depression on Aug. 4, the company delayed announcing its list price and the CFO hinted that Sage is considering reducing its workforce and pipeline. 
  • Drug shortages give rise to compounding pharmacies

    Private equity firms and hospitals are investing in compounding pharmacies as hundreds of drug shortages afflict healthcare, The Wall Street Journal reported Aug. 7. 
  • Fla. VA hospital pharmacists vote 'no confidence' in leadership

    More than 90 percent of pharmacists at a Veterans Affairs hospital in Tampa, Fla., who are part of the American Federation of Government Employees passed a vote of no confidence in their leaders Aug. 4, the Tampa Bay Times reported. 
  • Specialty drugs predicted to drive hospital spend up 3.4% in 2024

    Neurology specialty drugs are expected to increase hospital pharmaceutical spend by 3.42 percent in 2024, according to a Vizient analysis. 
  • UHS pharmacy leader tapped as ASHP president

    Leigh Briscoe-Dwyer, PharmD, the system pharmacy director of United Health Services' hospitals in Johnson City, N.Y., is now president of the American Society of Health-System Pharmacists. 
  • 1st pill for postpartum depression gets FDA approval

    The first pill to treat postpartum depression was approved by the FDA Aug. 4, offering a new treatment option for about 500,000 women who develop the condition annually.
  • Pfizer places 12 solutions on emergency order list

    Twelve solutions made at Pfizer's Rocky Mount, N.C., facility — which a tornado struck in July — must now be ordered directly from the drugmaker's emergency ordering system, according to an Aug. 3 letter sent to customers. 
  • 8 drugs now in shortage

    Eight drugs were recently added to the hundreds-long, growing list of medications in short supply, according to the FDA and the American Society of Health-System Pharmacists.
  • CDC advisory committee recommends AstraZeneca + Sanofi's infant RSV immunization

    A CDC advisory committee has unanimously recommended AstraZeneca and Sanofi's jointly developed RSV immunization for infants who are younger than 8 months, according to an Aug. 3 press release. 
  • Mark Cuban pharmacy's collaborations, partnerships

    Mark Cuban Cost Plus Drug Co. has teamed up with numerous companies, including pharmacy benefit managers and independent pharmacies. 
  • GSK sues Pfizer over RSV shot

    GSK filed a lawsuit against Pfizer on Aug. 2, claiming Pfizer's respiratory syncytial virus vaccine infringes on patents related to its own RSV shot.
  • New York hospital's plan to 'unlock' hard-to-access drugs

    The Brooklyn Hospital, based in New York City, is teaming up with Clearway Health to gain access to medications that regional hospitals can have difficulty obtaining.
  • Compounding pharmacy CAPS recalls 13K bags of cardioplegia

    Central Admixture Pharmacy Services, a nationwide compounding pharmacy business that sells to hospitals and outpatient facilities, voluntarily recalled more than 13,000 bags of cardioplegia because of sterility concerns. 
  • FDA outlines plan to boost supply of ADHD, binge-eating drugs

    The FDA and Drug Enforcement Administration are calling on stakeholders throughout the pharmaceutical supply chain to do all they can to boost available quantities of stimulant medications for the treatment of ADHD, binge-eating and narcolepsy, according to an Aug. 1 joint statement.
  • Acid poured on drug quality data: FDA reveals more on Intas violations

    Months after the FDA reported multiple violations at an Intas Pharmaceuticals plant in India and blocked imports, the agency shared more details Aug. 1, including a report of an analyst pouring acid in a trash can filled with drug quality documents. 
  • Hospital pharmacy teams can't afford to fight with drugmakers, Ochsner leader says

    The pharmacy team at New Orleans-based Ochsner Health is "pretty much begging" drug companies for critical drugs that are in short supply, according to Ryan Pepper, assistant vice president of pharmacy supply chain. 
  • Pfizer laying off 69 in Illinois

    Pharmaceutical giant Pfizer is laying off 69 employees in Lake Forest, Illinois, according to WARN filings published July 25.
  • Providence's new pharmacy offers national delivery, virtual services

    Renton, Wash.-based Providence's pharmacy business, Credenda Health, opened its 22nd pharmacy in Portland, Ore. 

Featured Whitepapers

Featured Webinars